D.B.T. MEDICAL LIMITEDActive

Company number 09737719Private limited companyIncorporated 2015

Key figures

£57,500+14.0%
Net assets 2025/26
-13.3%
Average annual change 2021/22–2025/26
050 k100 k150 k200 k2021/222022/232023/242024/252025/26

D.B.T. MEDICAL LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2021/222022/232023/242024/252025/26
Filed accounts2021/22–2025/26
2021/222022/232023/242024/252025/26
Profit for the year————7,069
Cash at bank and in hand95,013147,462139,537188,212126,008
Total assets131,026175,595181,494243,346145,370
Total liabilities29,45341,97316,838—87,870
Net assets / total equity101,573133,622164,65650,43157,500
Average number of employees22220

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: D.B.T. MEDICAL LIMITED

Company

D.B.T. MEDICAL LIMITED is a private limited company registered with Companies House under company number 09737719. It was incorporated on 18 Aug 2015. Its status is active. The registered office is in Manchester (M3). Its nature of business (SIC 2007) is manufacture of other rubber products (22190).

Accounts

The latest accounts in the database are for 2025/26 (period ending 28 Feb 2026); the company files small company accounts (filleted). Profit for the year was £7,069. Net assets were £57,500, up 14% on the previous year. Cash at bank and in hand was £126,008. Total assets were £145,370 and total liabilities £87,870. The company had an average of 0 employees. Figures are available for 5 financial years (2021/22–2025/26).

Control and charges

The company has 1 current director. One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Nov 2027. The next confirmation statement is due by 31 Aug 2027.